8 results
P
circulating miR-1, miR-133, miR-208, miR-499
I/C
O
diagnostic values in AMI
P
patients with cocaine-associated chest pain
I/C
cocaine use, low risk patients, mixed risk patients
O
acute myocardial infarction (AMI)
P
patients with acute myocardial infarction and multivessel disease
I/C
FFR-guided PCI, angiography-guided PCI
O
increased QALYs, cost savings
P
acute mild ischemic stroke (AMIS)
I/C
dual antiplatelet therapy (DAPT) with aspirin and clopidogrel, single antiplatelet therapy (SAPT) with only aspirin or clopidogrel
O
90-day Modified Rankin Scale (mRS) Score (MRS score 0-1), symptomatic intracranial hemorrhage (SICH), and 90-day mortality
P
patients with acute myocardial infarction (AMI), healthy controls, symptomatic controls
I/C
Mir-133a analysis, healthy vs. symptomatic controls
O
diagnostic performance, area under the summary receiver operator characteristic curve (AUC)
P
COVID-19 adult patients
I/C
cardiovascular system complications, control group
O
23.45% prevalence of cardiovascular complications
P
heart failure, myocardial infarction, advanced chronic kidney disease
I/C
steroidal mineralocorticoid receptor antagonists, placebo
O
heart failure hospitalizations, mortality
P
stable coronary artery disease (CAD) patients
I/C
coronary bypass (CABG), stenting, optimal medical therapy (OMT), OMT, CABG, durable-polymer-CoCr-everolimus-eluting stent, bio-absorbable-polymer-CoCr-sirolimus eluting stent
O
all-cause mortality, myocardial infarction (MI)